CTX-GLS 1000mg Injection
Marketer
GLS Pharma Ltd.
Salt Composition
Cyclophosphamide (1000mg)
Overview CTX-GLS 1000mg Injection
CTX-GLS 1000mg injection combats various cancers and serves as a treatment option for pediatric nephrotic syndrome when other therapies prove ineffective. Its application may extend to other conditions as directed by a physician. Administered intravenously by a medical professional, ideally at the same time daily, the dosage and frequency are determined by your doctor based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinuation should only occur under medical guidance. Common side effects include nausea, vomiting, alopecia, pyrexia, and hematuria; persistent or worsening symptoms warrant immediate medical attention. Preventive measures may be available. Due to its potency, serious side effects are possible. This medication can compromise immune function and potentially impact blood, liver, and kidney health, necessitating regular blood monitoring. Increased fluid intake to promote urination is advised to safeguard kidney function. Prior to treatment, disclose any pre-existing liver or kidney conditions, or the use of anti-infective medications. Interactions with other drugs are possible, thus comprehensive medication disclosure to your physician is essential. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout the treatment period to prevent conception.
Primary Ingredients of CTX-GLS 1000mg Injection
No text provided to rephrase.
Uses of CTX-GLS 1000mg Injection
Malignancy/Kidney disease with severe proteinuria
Major Benefits of CTX-GLS 1000mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of CTX-GLS 1000mg Injection:
- Vomiting
- Nausea
- Hair loss
- Fever
- Blood in urine
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use CTX-GLS 1000mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How CTX-GLS 1000mg Injection works:
CTX-GLS 1000mg Injection is a cancer treatment utilizing alkylation. Its mechanism involves disrupting the DNA and RNA of malignant cells, thus inhibiting their proliferation and growth, ultimately combating cancer.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with a 1000mg injection of CTX-GLS is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering CTX-GLS 1000mg Injection during pregnancy is contraindicated due to established fetal risk. Exceptions may exist in critical circumstances where the physician determines the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of CTX-GLS 1000mg Injection is contraindicated during lactation. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering CTX-GLS 1000mg Injection may induce adverse reactions, potentially impairing driving capabilities. These reactions can include dizziness, blurred vision, or visual disturbances, thus affecting driving ability.
KidneyCAUTION
Administration of CTX-GLS 1000mg Injection requires careful consideration in individuals with significant renal impairment. Dosage modification of CTX-GLS 1000mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
The 1000mg CTX-GLS injection requires careful administration to individuals with hepatic impairment. Dosage modification of the 1000mg CTX-GLS injection might be necessary. Physician consultation is advised.
What if you forget to take CTX-GLS 1000mg Injection :
NA
Facts to Know About CTX-GLS 1000mg Injection
| Label | Value |
|---|---|
| Chemical Type | Nitrogen mustard agents |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
| Actions | Alkylating compound |
3,018 People bought this recently